Free tool
Diagnostics stocks
We cover 1 company grouped under the Diagnostics theme. The median market value in the group is $14.20M. Across the group, the median move over the past trading day is +4.82%. Price change over the past year runs from −71.0% to −71.0% across the middle 80 percent of the group, with a median of −71.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 150 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GSS.AX | Genetic Signatures Limited | $14.20M | Micro cap | −71.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.